Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jessica Katharine Dyson

Showing results (1-10 of 16) with videos related to

Pageof 2
Sort By:
Alimentary Pharmacology & Therapeutics|October 22, 2022
Editorial: autoimmune hepatitis and metabolic syndrome-associated disease development-an important question but only part of the answer?Geraldine Carroll, Jessica Katharine Dyson
Gastroenterology|December 19, 2020
Bezafibrate for the Treatment of Cholestatic Pruritus: Time for a Change in Management?Jessica Katharine Dyson, David Emrys Jeffreys Jones
Clinical Medicine (London, England)|October 11, 2014
Lesson of the month 2: Severe reactivation of hepatitis B after immunosuppressive chemotherapyJessica Katharine Dyson, Mark Hudson, Stuart McPherson
Expert Opinion on Emerging Drugs|April 8, 2020
Emerging drugs for the treatment of primary biliary cholangitisNaw April Phaw, Jessica Katharine Dyson, David Jones
Expert Opinion on Investigational Drugs|October 4, 2022
Seladelpar: an investigational drug for the treatment of early-stage primary biliary cholangitis (PBC)Aaron Wetten, David Emrys Jeffreys Jones, Jessica Katharine Dyson
Expert Opinion on Pharmacotherapy|June 14, 2021
Specific considerations for the management of primary biliary cholangitis: are the drug treatment options good enough?Aaron Wetten, David Emrys Jeffreys Jones, Jessica Katharine Dyson
Digestive Diseases and Sciences|August 28, 2020
Understanding Fatigue in Primary Biliary CholangitisNaw April Phaw, Jessica Katharine Dyson, George Mells, et al.
Expert Review of Gastroenterology & Hepatology|November 2, 2020
Managing cognitive symptoms and fatigue in cholestatic liver diseaseNaw April Phaw, Jessica Leighton, Jessica Katharine Dyson, et al.
Alimentary Pharmacology & Therapeutics|August 15, 2020
Review article: experimental therapies in autoimmune hepatitisNeil Halliday, Jessica Katharine Dyson, Douglas Thorburn, et al.
JHEP Reports : Innovation in Hepatology|January 21, 2021
Geo-epidemiology and environmental co-variate mapping of primary biliary cholangitis and primary sclerosing cholangitisJessica Katharine Dyson, Alasdair Blain, Mark David Foster Shirley, et al.
Pageof 2

Showing results (1-10 of 16) with videos related to

Sort By:
Pageof 2
Alimentary Pharmacology & Therapeutics|October 22, 2022
Editorial: autoimmune hepatitis and metabolic syndrome-associated disease development-an important question but only part of the answer?Geraldine Carroll, Jessica Katharine Dyson
Gastroenterology|December 19, 2020
Bezafibrate for the Treatment of Cholestatic Pruritus: Time for a Change in Management?Jessica Katharine Dyson, David Emrys Jeffreys Jones
Clinical Medicine (London, England)|October 11, 2014
Lesson of the month 2: Severe reactivation of hepatitis B after immunosuppressive chemotherapyJessica Katharine Dyson, Mark Hudson, Stuart McPherson
Expert Opinion on Emerging Drugs|April 8, 2020
Emerging drugs for the treatment of primary biliary cholangitisNaw April Phaw, Jessica Katharine Dyson, David Jones
Expert Opinion on Investigational Drugs|October 4, 2022
Seladelpar: an investigational drug for the treatment of early-stage primary biliary cholangitis (PBC)Aaron Wetten, David Emrys Jeffreys Jones, Jessica Katharine Dyson
Expert Opinion on Pharmacotherapy|June 14, 2021
Specific considerations for the management of primary biliary cholangitis: are the drug treatment options good enough?Aaron Wetten, David Emrys Jeffreys Jones, Jessica Katharine Dyson
Digestive Diseases and Sciences|August 28, 2020
Understanding Fatigue in Primary Biliary CholangitisNaw April Phaw, Jessica Katharine Dyson, George Mells, et al.
Expert Review of Gastroenterology & Hepatology|November 2, 2020
Managing cognitive symptoms and fatigue in cholestatic liver diseaseNaw April Phaw, Jessica Leighton, Jessica Katharine Dyson, et al.
Alimentary Pharmacology & Therapeutics|August 15, 2020
Review article: experimental therapies in autoimmune hepatitisNeil Halliday, Jessica Katharine Dyson, Douglas Thorburn, et al.
JHEP Reports : Innovation in Hepatology|January 21, 2021
Geo-epidemiology and environmental co-variate mapping of primary biliary cholangitis and primary sclerosing cholangitisJessica Katharine Dyson, Alasdair Blain, Mark David Foster Shirley, et al.
Pageof 2